A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

Clinical trial NCT07472491 · RECRUITING

Trial details

NCT number: NCT07472491
Sponsor: GE Healthcare
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Known or Highly Suspected Central Nervous System (CNS) Lesion Known or Highly Suspected Body (Excluding CNS) Lesion

Start date: 2026-04-01
Primary completion: 2027-11-30
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.